Close
Help
Need Help?



New Journal of Cell Death Call for Papers

Posted Wed, Sep, 19,2012

The Editor in Chief, Dr Garry Walsh, is pleased to announce a new call for papers for Journal of Cell Death. Submissions are being accepted now.All authors who submit their manuscripts to Libertas will benefit from:Professional Manuscript EditingConvenient 3-step online manuscript submissionNo space restrictions or color figure chargesOptional immediate publicationInclusion of your article in: Chi...

Continue Reading →

Posted in: Calls for Papers

Bioinformatics and Biology Insights Added to ProQuest Biological Sciences

Posted Wed, Sep, 19,2012

We are pleased to announce the addition of Bioinformatics and Biology Insights to Biological Sciences, a ProQuest database.ProQuest Biological Sciences Database includes full text, abstracts, and citations from over 4.5 million sources. Disciplines covered include biomedicine, biotechnology, zoology and ecology, agriculture, and veterinary science. The database is updated monthly and offers reader...

Continue Reading →

Open Access Visibility Statistics for Japanese Clinical Medicine

Posted Wed, Sep, 19,2012

Articles published in open access journals like Japanese Clinical Medicine are likely to receive more citations and a higher level of visibility than articles published in restricted access journals.Libertas’ goal is to maximize visibility for all articles published in Japanese Clinical Medicine and articles in the journal have been viewed more than 32,838 times since 2008. In addition to th...

Continue Reading →

Integrative Medicine Insights Added to Gale InfoTrac Custom Journals

Posted Wed, Sep, 19,2012

Libertas is pleased to announce that Integrative Medicine Insights has now been added to Gale's InfoTrac Custom Journals database.GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Integrative Medicine Insights in GALE's InfoTrac Custom Journals will incre...

Continue Reading →

Most read paper in Biomarkers in Cancer

Posted Wed, Sep, 19,2012

Biomarkers in Cancer is an open access journal, meaning all articles are available for anyone to download freely without restriction. Open access journals are renowned for having high levels of article visibility compared to traditional subscription journals.One good example of how open access journals can offer high visibility is 'Identification of Gene Networks Associated with Acute Myeloid ...

Continue Reading →

International Journal of Tryptophan Research Added to Gale Academic OneFile

Posted Wed, Sep, 19,2012

Libertas is pleased to announce that International Journal of Tryptophan Research has now been added to Gale's Academic OneFile database.GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of International Journal of Tryptophan Research in GALE's Academic OneF...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
I would like to say that this is the most author-friendly editing process I have experienced in over 50 publications. The publishing process of this journal was a most pleasant and productive experience. I was particularly impressed with the regular updates of the progress of my submission. My experience with Libertas Academica was excellent.
Dr Ling Hong Tseng (Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and University of Chang Gung School of Medicine, Taiwan)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results